Compared with many countries that must rely solely on importing their prescription medicines, Canada is fortunate to have extensive domestic generic pharmaceutical manufacturing capacity and capabilities.

This capacity includes manufacturing, testing, packaging, warehousing distribution and research and development facilities based primarily in Ontario and Quebec. Generic companies own and operate the largest pharmaceutical manufacturing facilities in Ontario, Quebec and Canada, and also own and operate the largest facility for the production of active pharmaceutical ingredients (APIs) in Canada.